0001213900-22-075595.txt : 20221128 0001213900-22-075595.hdr.sgml : 20221128 20221128182604 ACCESSION NUMBER: 0001213900-22-075595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221123 FILED AS OF DATE: 20221128 DATE AS OF CHANGE: 20221128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannon Kara CENTRAL INDEX KEY: 0001913009 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 221427614 MAIL ADDRESS: STREET 1: 527 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2022-11-23 0 0000316253 ENZO BIOCHEM INC ENZ 0001913009 Cannon Kara 527 MADISON AVE NEW YORK NY 10022 0 1 0 0 Chief Operating Officer Stock Option (to acquire Common Stock) 1.97 2022-11-23 4 A 0 200000 0 A 2023-11-23 2027-11-23 Common Stock 200000 200000 D Stock Option (to acquire Common Stock) 2.98 2023-03-24 2027-03-24 Common Stock 87500 87500 D Stock Option (to acquire Common Stock) 3.36 2023-02-11 2027-02-11 Common Stock 87500 87500 D Stock Option (to acquire Common Stock) 2.63 2022-01-11 2026-01-11 Common Stock 55400 55400 D Stock Option (to acquire Common Stock) 2.2 2021-02-24 2025-02-24 Common Stock 55400 55400 D Stock Option (to acquire Common Stock) 2.8 2020-01-03 2024-01-03 Common Stock 52000 52000 D Stock Option (to acquire Common Stock) 4.42 2019-07-31 2023-07-30 Common Stock 35000 35000 D The Reporting Person was granted 200,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023. The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date. /s/ Kara Cannon 2022-11-28